InvestorsHub Logo
icon url

kimovoz

11/20/19 7:44 PM

#229004 RE: marzan #229001

Marzan, agreed. At the very minimum, your points 1 and 3 would require some sort of agreement.

Kim
icon url

Atom0aks

11/20/19 7:44 PM

#229005 RE: marzan #229001

how could they legally patent the use of V in their combo patent without infringing the owner rights of Amarin? How could FDA approve such a cohort when found efficacious in the trial? How could GILD ensure they get a constant supply of V if they don't have an agreement with Amarin?



Patents grant applicants with the right to EXCLUDE, not a right to MAKE. You could submit a patent today using Vascepa, that if approved, would prevent Amarin from manufacturing your patented product. It's a strategy commonly employed by patent trolls. Of course, you would need Amarin's permission (usually through a licensing agreement) to use Vascepa to make your patented product.

As for a supply of Vascepa, they probably source it from a wholesaler like any other pharmacy, not necessarily through a partnership with Amarin.